Article Details

« Back

Enrolling more minority patients in cancer clinical trials

Tulane gets $2 million federal grant

Tulane University School of Medicine has received $2 million from the National Cancer Institute to increase the enrollment of minority cancer patients in tests of promising drugs. The grant's purpose is to find and enroll patients who otherwise would not have access to such treatments, said Dr. William "Rusty" Robinson, Tulane's head of gynecologic oncology.

The award also will pay for an educator who will build awareness of cancer-prevention studies, he said.

He and Dr. Bridgette Collins-Burow, assistant professor of medicine in the Section of Hematology/Oncology, are the project's principal investigators.

Dr. Eboni Price-Haywood, assistant professor of internal medicine, will serve as co-program director for community clinics cancer prevention studies; and Dr. Roy Weiner, associate dean for clinical research and training, will serve as associate program director, providing senior leadership and guidance.

Tulane's Minority-Based Community Clinical Oncology Program, which will conduct the work, is one of 17 programs across the country that bring in population groups that ordinarily aren't involved in cancer research.

For more information, call 504.988.6121.

Original article


Search top vendors, suppliers, services providers & more